Immutep Stock (NASDAQ: IMMP) stock price, news, charts, stock research, profile.
You can purchase shares of Immutep (NASDAQ:IMMP) through any online brokerage.
Other companies in Immutep’s space includes: Valneva (NASDAQ:VALN), 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR), Sage Therapeutics (NASDAQ:SAGE) and aTyr Pharma (NASDAQ:ATYR).
Immutep has a consensus price target of $9.00.
The stock price for Immutep (NASDAQ: IMMP) is $1.97 last updated December 24, 2024 at 4:54 PM EST.
There are no upcoming dividends for Immutep.
Immutep’s H1 earnings are confirmed for Thursday, February 27, 2025.
There is no upcoming split for Immutep.
Immutep is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.